ArticleClinical cancer research : an official journal of the American Association for Cancer Research2025

A Phase I Clinical Trial Adding OX40 Agonism to In Situ Therapeutic Cancer Vaccination in Patients with Low-Grade B-cell Lymphoma Highlights Challenges in Translation from Mouse to Human Studies.

Tanaya Shree et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.